A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 6, 2009, Pages 1417-1424

  Khan, Tanveer A ^a   Schnickel, Gabriel ^a   Ross, David ^a   Bastani, Sam ^a   Laks, Hillel ^a   Esmailian, Fardad ^a   Marelli, Daniel ^a   Beygui, Ramin ^a   Shemin, Richard ^a   Watson, Larry ^a   Vartapetian, Irina ^a   Ardehali, Abbas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOPULMONARY HEMODYNAMICS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FLUSHING; GRAFT RECIPIENT; HEART INDEX; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MALE; OXYGEN SATURATION; OXYGENATION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VASODILATATION;

ADMINISTRATION, INHALATION; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; CROSS-OVER STUDIES; EPOPROSTENOL; FEMALE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; OXYGEN CONSUMPTION; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY ARTERY; TREATMENT OUTCOME;

EID: 71649091144     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.04.063     Document Type: Article

References (25)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
2. Griepp R.B., Stinson E.B., Dong Jr. E., Clark D.A., and Shumway N.E. Determinants of operative risk in human heart transplantation. Am J Surg 122 (1971) 192-197
3. Whitson B.A., Prekker M.E., Herrington C.S., Whelan T.P., Radosevich D.M., Hertz M.I., et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 26 (2007) 1004-1011
4. Arcasoy S.M., Fisher A., Hachem R.R., Scavuzzo M., and Ware L.B. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant 24 (2005) 1483-1488
5. Ardehali A., Hughes K., Sadeghi A., Esmailian F., Marelli D., Moriguchi J., et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72 (2001) 638-641
6. Kieler-Jensen N., Lundin S., and Ricksten S.E. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant 14 (1995) 436-443
7. Ardehali A., Laks H., Levine M., Shpiner R., Ross D., Watson L.D., et al. A prospective trial of inhaled nitric oxide in clinical lung transplantation. Transplantation 72 (2001) 112-115
8. Date H., Triantafillou A.N., Trulock E.P., Pohl M.S., Cooper J.D., and Patterson G.A. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 111 (1996) 913-919
9. Adatia I., Lillehei C., Arnold J.H., Thompson J.E., Palazzo R., Fackler J.C., et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 57 (1994) 1311-1318
10. Kirmse M., Hess D., Fujino Y., Kacmarek R.M., and Hurford W.E. Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System. Chest 113 (1998) 1650-1657
11. Welte M., Zwissler B., Habazettl H., and Messmer K. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25 (1993) 329-340
12. Haraldsson A., Kieler-Jensen N., and Ricksten S.E. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10 (1996) 864-868
13. Haraldsson A., Kieler-Jensen N., Nathorst-Westfelt U., Bergh C.H., and Ricksten S.E. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114 (1998) 780-786
14. Fiser S.M., Cope J.T., Kron I.L., Kaza A.K., Long S.M., Kern J.A., et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 981-982
15. Mikhail G., Gibbs J., Richardson M., Wright G., Khaghani A., Banner N., et al. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J 18 (1997) 1499-1504
16. Walmrath D., Schneider T., Schermuly R., Olschewski H., Grimminger F., and Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153 (1996) 991-996
17. De Wet C.J., Affleck D.G., Jacobsohn E., Avidan M.S., Tymkew H., Hill L.L., et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 127 (2004) 1058-1067
18. Young J.D., Dyar O., Xiong L., and Howell S. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med 20 (1994) 581-584
19. Moncada S., Gryglewski R., Bunting S., and Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263 (1976) 663-665
20. Haraldsson A., Kieler-Jensen N., Wadenvik H., and Ricksten S.E. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Intensive Care Med 26 (2000) 188-194
21. Meade M.O., Granton J.T., Matte-Martyn A., McRae K., Weaver B., Cripps P., et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 167 (2003) 1483-1489
22. Trachte A.L., Lobato E.B., Urdaneta F., Hess P.J., Klodell C.T., Martin T.D., et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 79 (2005) 194-197
23. Namachivayam P., Theilen U., Butt W.W., Cooper S.M., Penny D.J., and Shekerdemian L.S. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 174 (2006) 1042-1047
24. Galie N., Ghofrani H.A., Torbicki A., Barst R.J., Rubin L.J., Badesch D., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
25. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., and Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 (2002) 2398-2403